<DOC>
	<DOCNO>NCT02393430</DOCNO>
	<brief_summary>To investigate clinical effect rebamipide chronic gastritis patient . Patients chronic gastritis randomly divide experimental group control group . The experimental group treat rebamipide 0.1g tid optimization life style , control group optimize life style 26 week . Upper gastrointestinal endoscopy perform patient evaluate severity gastritis modify Lanza score ( MLS ) histology update Sydney system treatment .</brief_summary>
	<brief_title>Clinical Effect Rebamipide Chronic Gastritis</brief_title>
	<detailed_description />
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>With symptom follow : epigastric pain , abdominal discomfort , abdominal distention , poor appetite , nausea , vomit diagnose chronic gastritis endoscopic pathological method agree join clinical trail</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>